Minneapolis Heart Institute Foundation/ Abbott Northwestern Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Henry, Timothy D
GenePHIT, NCT05598333: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

Recruiting
2
150
US
AB-1002, Gene Therapy, NAN-101
Asklepios Biopharmaceutical, Inc.
Congestive Heart Failure
10/26
12/30
NAN-CS101, NCT04179643: NAN-101 in Patients With Class III Heart Failure

Recruiting
1
12
US
3 x 10e13vg NAN-101
Asklepios Biopharmaceutical, Inc.
Congestive Heart Failure, Heart Failure, Heart Disease, Ischemic, Cardiovascular Diseases, Heart Failure, Systolic, Heart Failure，Congestive, Heart Arrhythmia, Heart Failure, Diastolic, Heart; Complications
12/26
12/26
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Recruiting
N/A
380
Canada, US
Arm 1: treatment with Neovasc Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry
Neovasc Inc., Shockwave Medical, Inc.
Refractory Angina
06/24
12/28
DISCOVER INOCA, NCT05288361: The Prospective Multi-center Registry

Recruiting
N/A
500
US
Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire, Acetylcholine Provocation
Yale University, Abbott
Ischemia and No Obstructive Coronary Artery Disease, Coronary Microvascular Dysfunction, Coronary Vasospasm, Endothelial Dysfunction, Microvascular Angina, Chest Pain With Normal Coronary Angiography
07/24
07/29

Download Options